[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pulmonary Function Testing Systems Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Cart-Based PFT Systems and Stationary PFT Systems), Test Type (Spirometry, Lung Volume, Gas Exchange Testing, Maximum Voluntary Ventilation, Oxygen Titration Test, and Others), Component (Hardware, Software, and Services), Application (Chronic Obstructive Pulmonary Disorder, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, and Others), and End User (Hospitals, Specialty Clinics, and Diagnostic Laboratories)

January 2023 | 220 pages | ID: PB140495AC3DEN
The Insight Partners

US$ 4,550.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global pulmonary function testing systems market size is expected to reach US$ 401.83 million by 2028 from US$ 274.10 million in 2022. The pulmonary function testing systems market is estimated to record a CAGR of 6.6% from 2022 to 2028.

The rising incidence of lung-related disorders and occupational lung diseases is contributing to the growing pulmonary function testing systems market size. However, the risk of cross-contamination and the lack of skilled professionals are hampering the market growth.

The global pulmonary function testing systems market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share of the pulmonary function testing systems market in 2021. The US held the largest market share of the North America pulmonary function test systems market. The market is expected to grow due to an increase in the prevalence of lung cancer and a rise in technological advancements and developments by companies across the country.

Growing Prevalence of Occupational Lung Diseases
Occupational lung disease is one of the most influential factors accelerating the demand for pulmonary function testing systems. As per The Johns Hopkins University 2023 report, repeated and long-term exposure to certain irritants on the job can lead to lung disease with long-lasting effects on the patients. For example, in certain occupations, people are more at risk of occupational lung diseases due to the nature of the location, work, and environment. Additionally, people working in a car garage or textile factory may be exposed to hazardous chemicals, dust, and fibers that result in lifetime lung problems if not diagnosed and treated. Moreover, asbestosis is caused by the inhalation of microscopic fibers of asbestos with disease progression and resulting in scarring of the lungs of people working in construction, manufacturing, and chemical refining. According to the American Lung Association, an estimated 1.3 million construction and industry workers are exposed to asbestos.
Pulmonary function testing plays a critical role in determining occupational lung disease among workers. As per the American College of Occupational and Environmental Medicine 2020 report, spirometry in the occupational health setting plays a critical role in the primary, secondary, and tertiary prevention of workplace-related lung disease. The aim of workplace spirometry is to identify workers who require further evaluation for occupational lung-related disorders. As spirometry testing is intended for both screening and clinical evaluations at the workplace, it is performed at small clinical practices, small-sized industries, and multiple plant medical departments within an industry. Further, to recognize the central role of spirometry in workplace respiratory programs, the American College of Occupational and Environmental Medicine (ACOEM) developed three spirometry position statements that advanced the occupational health practice.

Based on type, the pulmonary function testing systems market is segmented into cart-based PFT systems and stationary PFT systems. The cart-based segment held the largest share of the market in 2022. Moreover, the cart-based segment is anticipated to register the highest CAGR in the market during the forecast period. The increasing prevalence of lung diseases is one of the major driving factors promoting the market growth for the portable PFT system segment. Furthermore, technological advancements in portable PFT systems and increasing availability of these advanced products are driving the market for the portable PFT system segment. In terms of test type, the pulmonary function testing systems market has been segmented into spirometry, lung volume, gas exchange testing, maximal voluntary ventilation, oxygen titration tests, and others. The spirometry segment held the largest share of the market in 2022. Moreover, the lung volume segment is anticipated to register the highest CAGR in the market during the forecast period. Based on component, the pulmonary function testing systems market has been segmented into hardware, software, and services. The hardware segment held the largest share of the market in 2022. Moreover, the software segment is anticipated to register the highest CAGR in the market during the forecast period. Based on application, the pulmonary function testing systems market has been segmented into chronic obstructive pulmonary disease (COPD), asthma, chronic shortness of breath, restrictive lung diseases, and others. The chronic obstructive pulmonary disease (COPD) segment is held the largest share of the market in 2022. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period. Based on end user, the pulmonary function testing systems market has been segmented into hospitals, specialty clinics, and diagnostic centers. The hospitals segment held the largest share of the market in 2022. Moreover, the specialty clinics segment is anticipated to register the highest CAGR in the market during the forecast period.

The World Health Organization (WHO), Dubai Health Authority, National Lung Health Education Program, Center for Disease Control and Prevention, European Respiratory Society, Organization for Economic Cooperation and Development, and Globocan are among the major primary and secondary sources referred to while preparing the report on the pulmonary function testing systems market.
1. INTRODUCTION

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Pulmonary Function Testing Systems Market – By Type
1.3.2 Global Pulmonary Function Testing Systems Market – By Test Type
1.3.3 Global Pulmonary Function Testing Systems Market – By Component
1.3.4 Global Pulmonary Function Testing Systems Market – By Application
1.3.5 Global Pulmonary Function Testing Systems Market – By End User
1.3.6 Global Pulmonary Function Testing Systems Market – By Geography

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. PULMONARY FUNCTION TESTING SYSTEMS MARKET – MARKET LANDSCAPE

4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East and Africa PEST Analysis
4.3 Experts’ Opinion

5. PULMONARY FUNCTION TESTING SYSTEMS MARKET – KEY MARKET DYNAMICS

5.1 Market Drivers
5.1.1 Rising Incidence of Lung-Related Disorders
5.1.2 Occupational Lung Diseases
5.2 Market Restraints
5.2.1 Risk of Cross-Contamination and Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Home Healthcare Pulmonary Function Testing Systems
5.4 Future Trends
5.4.1 Technological Advancements in Pulmonary Function Testing Systems
5.5 Impact Analysis

6. PULMONARY FUNCTION TESTING SYSTEMS MARKET– GLOBAL ANALYSIS

6.1 Global Pulmonary Function Testing Systems Market Revenue Forecast and Analysis
6.2 Global Pulmonary Function Testing Systems Market Revenue Forecast and Analysis
6.3 Market Positioning of Key Players
6.3.1.1 MGC Diagnostics
6.3.1.2 Vyaire Medical Inc

7. PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS – BY TYPE

7.1 Overview
7.2 Pulmonary Function Testing Systems Market, By Type, 2021 & 2028 (%)
7.3 Cart-Based PFT Systems
7.3.1 Overview
7.3.2 Cart-Based PFT Systems: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Stationary PFT Systems
7.4.1 Overview
7.4.2 Stationary PFT Systems: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)

8. PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS – BY TEST TYPE

8.1 Overview
8.2 Pulmonary Function Testing Systems Market, By Test Type, 2021 & 2028 (%)
8.3 Spirometry
8.3.1 Overview
8.3.2 Spirometry: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Lung Volume
8.4.1 Overview
8.4.2 Lung Volume: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.5 Gas Exchange Testing
8.5.1 Overview
8.5.2 Gas Exchange Testing: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.6 Maximal Voluntary Ventilation
8.6.1 Overview
8.6.2 Maximal Voluntary Ventilation: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.7 Oxygen Titration Test
8.7.1 Overview
8.7.2 Oxygen Titration Test: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.8 Others Test
8.8.1 Overview
8.8.2 Others: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)

9. PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS – BY COMPONENT

9.1 Overview
9.2 Pulmonary Function Testing Systems Market, By Component, 2021 & 2028 (%)
9.3 Hardware
9.3.1 Overview
9.3.2 Hardware: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
9.4 Software
9.4.1 Overview
9.4.2 Software: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
9.5 Services
9.5.1 Overview
9.5.2 Services: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)

10. PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS – BY APPLICATION

10.1 Overview
10.2 Pulmonary Function Testing Systems Market, By Application, 2021 & 2028 (%)
10.3 Chronic Obstructive Pulmonary Disease
10.3.1 Overview
10.3.2 Chronic Obstructive Pulmonary Disease: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.4 Asthma
10.4.1 Overview
10.4.2 Asthma: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.5 Chronic Shortness of Breath
10.5.1 Overview
10.5.2 Chronic Shortness of Breath: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.6 Restrictive Lung Disease
10.6.1 Overview
10.6.2 Restrictive Lung Disease: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)

11. PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS – BY END-USER

11.1 Overview
11.2 Pulmonary Function Testing Systems Market, By End-User, 2021 & 2028 (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
11.4 Specialty Clinics
11.4.1 Overview
11.4.2 Specialty Clinics: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
11.5 Diagnostic Laboratories
11.5.1 Overview
11.5.2 Diagnostic Laboratories: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)

12. PULMONARY FUNCTION TESTING SYSTEMS MARKET – REVENUE AND FORECAST TO 2028 – GEOGRAPHIC ANALYSIS

12.1 North America: Pulmonary Function Testing Systems Market
12.1.1 Overview
12.1.2 North America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3 North America: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.4 North America: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.5 North America: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.6 North America: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.7 North America: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.7.1 US: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.1.1 Overview
12.1.7.1.2 US: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.1.3 US: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.7.1.4 US: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.7.1.5 US: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.7.1.6 US: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.7.1.7 US: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.7.2 Canada: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.2.1 Overview
12.1.7.2.2 Canada: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.2.3 Canada: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.7.2.4 Canada: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.7.2.5 Canada: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.7.2.6 Canada: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.7.2.7 Canada: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.7.3 Mexico: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.3.1 Overview
12.1.7.3.2 Mexico: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.3.3 Mexico: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.7.3.4 Mexico: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.7.3.5 Mexico: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.7.3.6 Mexico: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.7.3.7 Mexico: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2 Europe: Pulmonary Function Testing Systems Market
12.2.1 Overview
12.2.2 Europe: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.3 Europe: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.4 Europe: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.5 Europe: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.6 Europe: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.7 Europe: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8 Europe: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
12.2.8.1 Germany: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.1 Overview
12.2.8.1.2 Germany: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.3 Germany: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.1.4 Germany: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.1.5 Germany: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.1.6 Germany: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.1.7 Germany: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.2 UK: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.1 Overview
12.2.8.2.2 UK: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.3 UK: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.2.4 UK: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.2.5 UK: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.2.6 UK: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.2.7 UK: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.3 France: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.1 Overview
12.2.8.3.2 France: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.3 France: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.3.4 France: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.3.5 France: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.3.6 France: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.3.7 France: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.4 Italy: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.1 Overview
12.2.8.4.2 Italy: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.3 Italy: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.4.4 Italy: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.4.5 Italy: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.4.6 Italy: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.4.7 Italy: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.5 Spain: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.1 Overview
12.2.8.5.2 Spain: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.3 Spain: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.5.4 Spain: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.5.5 Spain: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.5.6 Spain: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.5.7 Spain: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.6 Rest of Europe: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.3 Rest of Europe: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.6.4 Italy: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.6.5 Italy: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.6.6 Italy: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.6.7 Italy: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3 Asia Pacific: Pulmonary Function Testing Systems Market
12.3.1 Overview
12.3.2 Asia Pacific: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.3 Asia Pacific: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.4 Asia Pacific: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.5 Asia Pacific: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.6 Asia Pacific: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.7 Asia Pacific: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8 Asia Pacific: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
12.3.8.1 China: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.1.1 Overview
12.3.8.1.2 China: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.1.3 China: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.1.4 China: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.1.5 China: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.1.6 China: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.1.7 China: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.2 Japan: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.2.1 Overview
12.3.8.2.2 Japan: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.2.3 Japan: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.2.4 Japan: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.2.5 Japan: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.2.6 Japan: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.2.7 Japan: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.3 India: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.3.1 Overview
12.3.8.3.2 India: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.3.3 India: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.3.4 India: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.3.5 India: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.3.6 India: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.3.7 India: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.4 South Korea: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.4.1 Overview
12.3.8.4.2 South Korea: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.4.3 South Korea: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.4.4 South Korea: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.4.5 South Korea: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.4.6 South Korea: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.4.7 South Korea: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.5 Australia: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.5.1 Overview
12.3.8.5.2 Australia: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.5.3 Australia: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.5.4 Australia: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.5.5 Australia: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.5.6 Australia: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.5.7 Australia: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.6 Rest of Asia Pacific: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.6.3 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.6.4 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.6.5 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.6.6 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.6.7 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.4 Middle East & Africa Exoskeleton Robotic System Market
12.4.1 Overview
12.4.2 Middle East & Africa Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.3 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.4 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.5 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.6 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.7 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End Use (US$ Mn)
12.4.8 Middle East & Africa Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Country (%)
12.4.8.1 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.1.1 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.1.2 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.8.1.3 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.8.1.4 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.8.1.5 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.8.1.6 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
12.4.8.2 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.2.1 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.2.2 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.8.2.3 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.8.2.4 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.8.2.5 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.8.2.6 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
12.4.8.3 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.3.1 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.3.2 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.8.3.3 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.8.3.4 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.8.3.5 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.8.3.6 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
12.4.8.4 Rest of Middle East and Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.4.1 Rest of Middle East and Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.4.2 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.8.4.3 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.8.4.4 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.8.4.5 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.8.4.6 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
12.5 South & Central America Pulmonary Function Testing Systems Market
12.5.1 Overview
12.5.2 South & Central America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.3 South & Central America: Pulmonary Function Testing Systems Market, by Type, 2019-2028 (US$ Million)
12.5.4 South & Central America: Pulmonary Function Testing Systems Market, by Test Type, 2019-2028 (US$ Million)
12.5.5 South & Central America: Pulmonary Function Testing Systems Market, by Component, 2019-2028 (US$ Million)
12.5.6 South & Central America: Pulmonary Function Testing Systems Market, by Application, 2019-2028 (US$ Million)
12.5.7 South & Central America: Pulmonary Function Testing Systems Market, by End-User, 2019-2028 (US$ Million)
12.5.8 South & Central America: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
12.5.8.1 Brazil: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.1.1 Brazil: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.1.2 Brazil: Pulmonary Function Testing Systems Market, by Type, 2019-2028 (US$ Million)
12.5.8.1.3 Brazil: Pulmonary Function Testing Systems Market, by Test Type, 2019-2028 (US$ Million)
12.5.8.1.4 Brazil: Pulmonary Function Testing Systems Market, by Component, 2019-2028 (US$ Million)
12.5.8.1.5 Brazil: Pulmonary Function Testing Systems Market, by Application, 2019-2028 (US$ Million)
12.5.8.1.6 Brazil: Pulmonary Function Testing Systems Market, by End-User, 2019-2028 (US$ Million)
12.5.8.2 Argentina: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.2.1 Argentina: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.2.2 Argentina: Pulmonary Function Testing Systems Market, by Type, 2019-2028 (US$ Million)
12.5.8.2.3 Argentina: Pulmonary Function Testing Systems Market, by Test Type, 2019-2028 (US$ Million)
12.5.8.2.4 Argentina: Pulmonary Function Testing Systems Market, by Component, 2019-2028 (US$ Million)
12.5.8.2.5 Argentina: Pulmonary Function Testing Systems Market, by Application, 2019-2028 (US$ Million)
12.5.8.2.6 Argentina: Pulmonary Function Testing Systems Market, by End-User, 2019-2028 (US$ Million)
12.5.8.3 Rest of South & Central America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.3.1 Rest of South & Central America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.3.2 Rest of South & Central America: Pulmonary Function Testing Systems Market, by Type, 2019-2028 (US$ Million)
12.5.8.3.3 Rest of South & Central America: Pulmonary Function Testing Systems Market, by Test Type, 2019-2028 (US$ Million)
12.5.8.3.4 Rest of South & Central America: Pulmonary Function Testing Systems Market, by Component, 2019-2028 (US$ Million)
12.5.8.3.5 Rest of South & Central America: Pulmonary Function Testing Systems Market, by Application, 2019-2028 (US$ Million)
12.5.8.3.6 Rest of South & Central America: Pulmonary Function Testing Systems Market, by End-User, 2019-2028 (US$ Million)

13. IMPACT OF COVID-19 PANDEMIC ON PULMONARY FUNCTION TESTING MARKET

13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13.5 South & Central America: Impact Assessment of COVID-19 Pandemic

14. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET – INDUSTRY LANDSCAPE

14.1 Overview
14.2 Growth Strategies in Pulmonary Function Testing Systems Market
14.3 Organic Growth Strategies
14.3.1 Overview
14.4 Inorganic Growth Strategies
14.4.1 Overview

15. COMPANY PROFILES

15.1 COSMED Srl
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 MGC Diagnostics Corp
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Morgan Scientific Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Minato Medical Science Co Ltd
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Schiller AG
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Chest MI Inc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Vyaire Medical Inc
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 ndd Medical Technologies Inc
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 PulmOne Advanced Medical Devices Ltd
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 KoKo PFT Ltd
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments

16. APPENDIX

16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES

Table 1. North America Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. US Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany Pulmonary Function Testing Systems Market, by End User – Reven


More Publications